← Leaderboards
Sharon Celeste Morley
Washington University
$6,198,580
Attributed
$6,198,580
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $741.7K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,198,580 · 6
By mechanism
R01$4,799,350 · 3
K08$567,496 · 1
R21$430,459 · 1
R56$401,275 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Jeffrey Koenitzer$700,328
- Ann M Craig$5,735,495
- Robert O Heuckeroth$13,588,589
- Richard Samuel Hotchkiss$18,878,445
- Vasant Muralidharan$5,780,978
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMolecularIn VivoMediatingGenerationsImmune ResponseAutoimmunityInfectionT-LymphocyteProductionPlayPredispositionVaccinesL-PlastinMigrationResearch PersonnelAllelesIn VitroPathway InteractionsCellsChemokineChimera OrganismBone MarrowAutoimmune Diseases
Grant awards (18)
Novel coenzyme Q6 variant reveals non-immune determinants of survival during pneumococcal sepsis$741,695
R01 · FY2025 · HL · contact PI
Novel coenzyme Q6 variant reveals non-immune determinants of survival during pneumococcal sepsis$739,362
R01 · FY2024 · HL · contact PI
Strength of TCR:self-pMHC interactions in the periphery instructs CD4+ T help cell responses$470,785
R01 · FY2023 · AI · contact PI
Strength of TCR:self-pMHC interactions in the periphery instructs CD4+ T help cell responses$470,785
R01 · FY2022 · AI · contact PI
Strength of TCR:self-pMHC interactions in the periphery instructs CD4+ T help cell responses$470,785
R01 · FY2021 · AI · contact PI
Actin regulatory proteins regulate alveolar macrophage pro-inflammatory signaling$401,275
R56 · FY2020 · AI · contact PI
HUMAN VARIANT IN CoQ BIOSYNTHESIS IMPAIRS LUNG IMMUNITY IN ACUTE PNEUMONIA$196,459
R21 · FY2020 · AI · contact PI
HUMAN VARIANT IN CoQ BIOSYNTHESIS IMPAIRS LUNG IMMUNITY IN ACUTE PNEUMONIA$234,000
R21 · FY2019 · AI · contact PI
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS$381,250
R01 · FY2018 · AI · contact PI
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS$381,250
R01 · FY2017 · AI · contact PI
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS$381,250
R01 · FY2016 · AI · contact PI
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS$381,250
R01 · FY2015 · AI · contact PI
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINS$380,938
R01 · FY2014 · AI · contact PI
Integration of T Cell Receptor and Chemokine Signaling in Thymocytes$114,196
K08 · FY2013 · AI · contact PI
Integration of T Cell Receptor and Chemokine Signaling in Thymocytes$114,196
K08 · FY2012 · AI · contact PI
Integration of T Cell Receptor and Chemokine Signaling in Thymocytes$114,196
K08 · FY2011 · AI · contact PI
Integration of T Cell Receptor and Chemokine Signaling in Thymocytes$111,688
K08 · FY2010 · AI · contact PI
Integration of T Cell Receptor and Chemokine Signaling in Thymocytes$113,220
K08 · FY2009 · AI · contact PI